Sicad, Analuna I.

HRN: 01-28-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/02/2025
04/09/2025
IV
Q8
500mg
T/c Acute Surgical Abdomen Prob Sec To Perforated Peptic Ulcer Disease
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: